Skip to main content
Article thumbnail
Location of Repository

BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy

By Kathryn J. Schlich-Bakker, Margreet G. E. M. Ausems, Maria Schipper, Herman F. J. ten Kroode, Carla C. Wárlám-Rodenhuis and Jan van den Bout

Abstract

This study assessed psychological distress during the first year after diagnosis in breast cancer patients approached for genetic counseling at the start of adjuvant radiotherapy and identified those vulnerable to long-term high distress. Of the approached patients some chose to receive a DNA test result (n = 58), some were approached but did not fulfill criteria for referral (n = 118) and some declined counseling and/or testing (n = 44). The comparative group consisted of patients not eligible for genetic counseling (n = 182) and was therefore not approached. Patients actively approached for genetic counseling showed no more long-term distress than patients not eligible for such counseling. There were no differences between the subgroups of approached patients. Predictors for long-term high distress or an increase in distress over time were pre-existing high distress and a low quality of life, having children, and having no family members with breast cancer. It is concluded that breast cancer patients can be systematically screened and approached for genetic counseling during adjuvant radiotherapy without imposing extra psychological burden. Patients vulnerable to long-term high distress already displayed high distress shortly after diagnosis with no influence of their medical treatment on their level of distress at long-term

Topics: Clinical Trial
Publisher: Springer US
OAI identifier: oai:pubmedcentral.nih.gov:2668630
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (1979). A classification of coping behavior based on multi-dimensional scaling of similarity ratings.
    2. (2006). A literature review of the psychological impact of genetic testing on breast cancer patients. Patient Educ Couns 62:13–20
    3. (2006). Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.
    4. (1994). Convergent validity of measures of post-traumatic stress disorder in a mixed military and civilian population.
    5. (2005). Depression and anxiety in women with early breast cancer: five year observational cohort study.
    6. Desseigne F et al (2002) Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result. Cancer Epidemiol Biomarkers Prev 11:97–104
    7. Duivenvoorden HJ et al (2007) Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing.
    8. (2003). Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis.
    9. Frets PG, Trijsburg RW et al (2001) Psychological impact of receiving a BRCA1/BRCA2 test result.
    10. (2004). Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.
    11. (1979). Impact of event scale: a measure of subjective stress.
    12. Lodder LN et al (2003) Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
    13. McLatchie E et al (2005) A 1-year prospective study of individual variation in distress, and illness perceptions, after treatment for breast cancer.
    14. (2006). Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer.
    15. (1996). Personality factors and breast cancer development: a prospective longitudinal study.
    16. (1998). Posttraumatic distress symptoms in operable breast cancer III: status one year after surgery.
    17. (2005). Prevention and management of hereditary breast cancer.
    18. (2000). Psychological distress two years after diagnosis of breast cancer: frequency and prediction. Patient Educ Couns 40:209–217
    19. (2005). Psychological impact of genetic testing for cancer susceptibility: an update of the literature.
    20. (1991). Psychosocial adjustment in women with breast cancer.
    21. (1990). Screening for adjustment disorders and major depressive disorders in cancer in-patients.
    22. (2006). Short-term psychological distress in patients actively approached for genetic counseling after diagnosis of breast cancer.
    23. (1982). Stress response syndromes and their treatment. In: Goldenberger L, Breznitz S (eds) Handbook of stress. Theoretical and clinical aspects.
    24. (2004). Stress response syndromes in women undergoing mammography: a comparison of women with and without a history of breast cancer. Psychosom Med 66:104–112 514 Breast Cancer Res Treat
    25. (1996). The European Organization for Research Treatment of Cancer breast cancer specific quality-of-life questionnaire module: first results from a three country field study.
    26. (1996). The genetic attributable risk of breast and ovarian cancer.
    27. (1983). The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361–370
    28. (2005). Too much too soon? Patients and health professionals’ views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40.
    29. (2003). Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
    30. (2005). Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients. Cancer Epidemiol Biomarkers Prev 14:1003–
    31. (1988). Utrechtse Copinglijst. Omgaan met problemen en gebeurtenissen. Swets & Zeitlinger,
    32. Verhoef LCG et al (2004) Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer.
    33. (2003). What do ratings of cancer – specific distress mean among women at high risk of breast and ovarian cancer?

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.